Image

Global Melasma Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Melasma Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Aug 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Melasma Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2,853.64 USD Million
Diagram Market Size (Forecast Year) USD 4,830.25 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Melasma Treatment Market, By Type (Epidermal, Dermal, Mixed, Others), Treatment Type (Medication, Laser Treatment, Skin Peels, Others), Route of Administration (Oral, Topical), End- Users (Hospitals, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2030.

Melasma Treatment Market

Melasma Treatment Market Analysis and Size

Melasma is a common skin condition characterized by the appearance of dark, discolored patches on the skin. It primarily affects the face, although it can also occur on other sun-exposed areas of the body, such as the forearms and neck. Melasma is more prevalent in women, particularly those with darker skin tones, but it can affect men as well. The exact cause of melasma is not fully understood, but several factors are believed to contribute to its development. These factors include hormonal changes, particularly during pregnancy or while taking hormonal contraceptives, exposure to ultraviolet (UV) radiation from the sun or tanning beds, and genetic predisposition. Hormonal fluctuations and UV exposure are thought to stimulate the production of melanin, the pigment responsible for skin color, leading to the formation of melasma patches.

Data Bridge Market Research analyses that the global melasma treatment market, which was USD 2,853.64 million in 2022, would rocket up to USD 4,830.25 million by 2030, and is expected to undergo a CAGR of 6.8% during the forecast period. This indicates that the market value of acute melasma dominates the product type segment of the global melasma treatment market owing to the increasing aging population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Melasma Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Type (Epidermal, Dermal, Mixed, Others), Treatment Type (Medication, Laser Treatment, Skin Peels, Others), Route of Administration (Oral, Topical), End- Users (Hospitals, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada, and Mexico in North America, Germany, Italy, the U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, the Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Glenmark Pharmaceuticals Ltd (India), Abbott (U.S.), La Pristine Bioceuticals Pvt Ltd (India), Galderma Laboratories (Switzerland), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceuticals Inc. (U.S.), Wockhardt (India), mesoestetic (India), LUTRONIC (South Korea), Cynosure Inc. (U.S.), Focus Medical (U.S.)

Market Opportunities

  • Increasing prevalence of melisma
  • Growing awareness and patient education

Market Definition

Melasma also referred to as chloasma faciei is a pigmentary skin disorder that causes brown patches on the face, especially on the bridge of the nose, cheeks, forehead and chin. It is more common in females than males and can also can appear on other parts of the body that get lots of sun. Hormone changes, particularly due to pregnancy and birth control pills, along with sun exposure, are the most common triggers for melisma.

Melasma Treatment Market Dynamics

Drivers

  • Increasing prevalence of melasma

The rising incidence of melasma worldwide is a significant driver for the market. Factors such as hormonal changes, sun exposure, and genetic predisposition contribute to the development of melasma. As the prevalence of melasma continues to increase, the demand for effective treatment options also grows.

  • Growing awareness and patient education

There is an increasing awareness among individuals about melasma and its impact on appearance and self-esteem. This awareness drives patients to seek treatment options to manage and reduce the visibility of melasma patches. Improved patient education through various channels, including online resources and awareness campaigns, also contributes to market growth.

  • Technological advancements in laser therapy

Laser technologies, such as fractional laser and intense pulsed light (IPL), have shown promising results in treating melasma. These technologies target and break down excess melanin in the skin, reducing the appearance of melasma patches. As technological advancements continue to enhance the efficacy and safety of laser therapy, the demand for these treatments increases, driving market growth.

  • Increasing focus on aesthetics and skincare

The growing emphasis on aesthetics, beauty, and skincare plays a significant role in the expansion of the market. People are increasingly concerned about their appearance and seek treatments to improve their skin tone and reduce pigmentation issues. The availability of effective melasma treatments caters to this demand and propels the market growth.

Opportunity

  • Rising disposable income

Increasing disposable income in many regions allows individuals to spend more on cosmetic and dermatological procedures. As affordability improves, more people can access and afford melasma treatment options, driving market growth.

  • Advancements in treatment options

The development of innovative and effective treatment options for melasma drives market growth. Researchers and pharmaceutical companies are continually exploring new therapies, topical creams, chemical peels, and laser technologies to improve the outcomes of melasma treatment. Advancements in treatment options provide more choices for patients and expand the market.

Restraints/Challenges

  • Limited treatment efficacy

Melasma can be a challenging condition to treat, and not all treatment options deliver consistent and satisfactory results for all patients. The effectiveness of various treatments can vary, and some individuals may not respond adequately to available therapies. This limitation can affect patient satisfaction and hinder the market growth.

  • Side effects and complications

Certain treatment modalities, such as topical creams or chemical peels, may be associated with side effects or complications. For example, topical creams containing hydroquinone may cause skin irritation or hypersensitivity reactions in some individuals. Chemical peels and laser therapies can also lead to temporary or long-term skin discoloration, redness, or scarring if not performed correctly. Concerns regarding potential side effects and complications can deter some individuals from seeking treatment.

This global melasma treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the melasma Treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In March 2023, Candela, a Canadian medical device company, announced that the picosecond laser system was approved both by the FDA and by Health Canada on Wednesday.Previously, the laser system had been approved for several indications, including acne scarring, benign pigmented lesions, tattoo removal, and wrinkles
  • In January 2023, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of the long-awaited SkinMedica® Even & Correct Collection. Clinically proven and formulated to deliver targeted results, these three products work separately and together to even skin tone and reduce the appearance of hyperpigmentation and dark spots on the face.

Global Melasma Treatment Market Scope

The global melasma treatment market is segmented on the basis of type, treatment type, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Epidermal
  • Dermal
  • Mixed
  • Others

Treatment Type

  • Medication
  • Laser Treatment
  • Skin Peels
  • Others

Route of Administration

  • Oral
  • Topical

End User

  • Hospitals
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

 Global Melasma Treatment Market Regional Analysis/Insights

The global melasma treatment market is analyzed, and market size insights and trends are provided by country, type, treatment type, route of administration, end users, and distribution channel as referenced above.

The countries covered in the melasma treatment market report are the U.S., Canada and Mexico in North America, Germany, Italy, the U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global melasma treatment market because of the increasing prevalence of melasma, growing investment in healthcare infrastructure is also boosting the growth of the market.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The melasma treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global melasma treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global melasma treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Melasma Treatment Market Share Analysis

The global melasma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the global melasma treatment market.

Some of the major players operating in the global melasma treatment market are:

  • Glenmark Pharmaceuticals Ltd (India)
  • Abbott (U.S.)
  • La Pristine Bioceuticals Pvt Ltd (India)
  • Galderma Laboratories (Switzerland)
  • Sun Pharmaceutical Industries Ltd (India)
  • Teva Pharmaceuticals Inc. (U.S.)
  • Wockhardt (India)
  • mesoestetic (India)
  • LUTRONIC (South Korea)
  • Cynosure Inc. (U.S.)
  • Focus Medical (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Melasma Treatment Market will be worth USD 4,830.25 million by 2030.
The Melasma Treatment Market Growth Rate is 6.8% during the forecast period.
The Increasing prevalence of melasma, Growing awareness and patient education, Technological advancements in laser therapy, and Increasing focus on aesthetics and skincare are the Growth drivers of the Melasma Treatment Market.
The type, treatment type, route of administration, end users, and distribution channel are the factors on which the Melasma Treatment Market research is based.
The Candela, a Canadian medical device company, announced that the picosecond laser system was approved both by the FDA and by Health Canada on Wednesday.Previously, the laser system had been approved for several indications, including acne scarring, benign pigmented lesions, tattoo removal, and wrinkes, and Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of the long-awaited SkinMedica® Even & Correct Collection. Clinically proven and formulated to deliver targeted results, these three products work separately and together to even skin tone and reduce the appearance of hyperpigmentation and dark spots on the face are the latest developments in the Melasma Treatment Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials